Macquarie Group Ltd reveals its "most compelling" stock ideas

• Fund size: $1Bn
• Asset allocation: 99% Australian equities, 1% cash
• Investment style: Blend of large cap stocks
• Fees: Management fee of 0.923% per annum and performance fees of 15% of outperformance of returns above the benchmark
• Fund performance: The fund's performance is outlined below. The fund has outperformed its benchmark since inception in 2005 with an annual gross return of 12.27% over the same period.

• BlueScope Steel Limited (ASX: BSL). Its share price is up 50% over the last year despite a slump in August after the announcement of the imminent departure of CEO Paul O'Malley, a softer outlook for FY18, and allegations of price fixing prompting an investigation by the competition watchdog the ACCC. BlueScope reported a net profit after tax of $715.9 million for FY17, up more than 100% on the previous year.
• Link Administration Holdings Ltd (ASX: LNK). Its share price is up 20% in the last 2 months and analysts at UBS have upgraded Link to a buy rating and increased the price target on its shares due to its defensive nature.
• ResMed Inc. (CHESS) (ASX: RMD). Its share price is up 43% over the last year. The company has been beating analysts' expectations leading to upgrades by Credit Suisse and Morgans.

Other overweight positions in this fund include Boral Limited (ASX: BLD), Reliance Worldwide Corporation Aus P Ltd (ASX: RWC) and Woodside Petroleum Limited (ASX: WPL).

Foolish takeaway

Overall, whilst the fund's performance has been really good since inception, past performance is not an indication of future performance. If a fund is not what you are after and you would like to go for it alone, you might want to have a look at these three Aussie companies that are taking over the world.